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ABSTRACT 
To date, it has remained unclear whether T cells infiltrating thy- 
roid, retroorbital, and pretibial tissue of patients with Graves’ oph- 
thalmopathy and pretibial dermopathy represent a primary immune 
response that is directed against certain antigenic determinants 
shared among these involved tissues. To characterize these T cells at 
the molecular level, we compared the T cell antigen receptor (TcR) 
variable (V) region gene usage in thyroid, retroorbital, pretibial tis- 
sue, and peripheral blood mononuclear cells of two patients with 
Graves’ disease, ophthalmopathy, and pretibial dermopathy. Ribo- 
nucleic acid was extracted, reverse transcribed, and amplified using 
the PCR and 22 Vol and 23 V/3 gene-specific oligonucleotide primers. 
The resulting TcR Va and VP transcripts were verified by Southern 
hybridization analysis using TcR C region-specific, digoxigenin-la- 
beled oligonucleotide probes. In addition, complementarity determin- 
ing regions 3 and junctional regions of TcR VP genes were sequenced. 
Marked similarities of intrathyroidal, retroorbital, and pretibial TcR 
Vol and V/3 gene repertoires were noted with respect to the degree of 
TcR V gene restriction and the patterns of individual V genes ex- 
pressed. Sequence analysis of junctional domains of VP families re- 
vealed oligoclonality of intrathyroidal, retroorbital, and pretibial T 
cells. In addition, certain conserved junctional motifs were shared by 
T cells derived the thyroid gland and the extrathyroidal sites. Our 
results suggest that in the two patients with Graves’ disease and 
extrathyroidal manifestations studied, similar antigenic determi- 
nants may have contributed to the recruitment and oligoclonal ex- 
pansion of T cells both within the thyroid gland and at the involved 
extrathyroidal sites. (J Clin Endocrinol Metab 81: 3733-3739, 1996) 
T HE ETIOLOGY of Graves’ ophthalmopathy (GO) and pretibial dermopathy (PTD) and the reasons for the 
preferential involvement of the retroorbital and pretibial 
space are poorly understood (l-5). During the active stages 
of GO, infiltration of the retroorbital tissue by mononuclear 
cells is frequently observed (1, 2). The cellular infiltrate 
within the retroorbital tissues in GO consists mainly of T 
lymphocytes, macrophages, and, to a lesser extent, B cells 
and natural killer cells (6-8). The T cell component includes 
both CD4+ and CD8+ T lymphocytes, many of which express 
CD45R0, suggesting that they are major histocompatibility 
complex (MHC) class I and II restricted memory T cells 
(8-10). PTD occurs in a small proportion of patients with 
Graves’ disease (GD), most of whom have ophthalmopathy 
and high serum titers of TSH receptor-directed antibodies 
(3-5). Both processes are likely to be driven by T cells that 
access and infiltrate the retroorbital and pretibial space via 
certain adhesion molecules and release various cytokines 
capable of stimulating cell proliferation, GAG synthesis, and 
the expression of immunomodulatory molecules in micro- 
vascular endothelial cells and fibroblasts (1, 2, 10-13). In 
support of this concept, retroorbital and pretibial fibroblasts 
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have recently been shown to act as targets of the autoimmune 
process in GO and PTD (14). However, although these mech- 
anisms may be sufficient to explain certain aspects of how 
GO and PTD may evolve and be propagated, the primary 
antigen for these presumed autoimmune manifestations has 
remained elusive. The close clinical association between the 
hyperthyroidism of GD, GO, and PTD suggests that the 
antigen responsible for these diverse conditions may be 
shared by the thyroid gland and extrathyroidal tissues (11). 
T cells specifically recognize processed antigens in con- 
junction with MHC molecules through their T cell receptors 
(TcR) which consist mostly of (Y- and p-chain heterodimers. 
The TcR a-chain consists of variable (V), joining (J), and 
constant (C) regions, whereas the p-chain consists of V, di- 
versity (D), joining, and constant regions. They are desig- 
nated Va!, JCX, and Ca or VP, Dp, Jp, and C/3, respectively. The 
antigen specificity of the TcR is defined by the V domains 
encoded by V, D, and J gene elements that are rearranged and 
joined during T cell differentiation. The clonotypic rear- 
rangement of germ-line V, D, J, and C genes provides for TcR 
recognition of a vast array of MHC-antigen complexes. The 
specific interaction of TcRs with MHC-peptide complexes is 
mediated by three Ig-like complementary-determining re- 
gions (CDRl, CDR2, and CDR3) (15). Germ-line V genes 
encode both the CDRl and CDR2 domains, which presum- 
ably contact polymorphic MHC determinants. The CDR3 
domain is encoded by both germ-line V and J genes and 
nontemplated nucleotide modifications (N regions) located 
at the V-J or V-D-J interface of rearranged TcR (Y and p genes, 
respectively. The recognition of MHC-peptide complexes by 
T cells is frequently characterized by the selective or re- 
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stricted use of particular TcR germ-line (V and J genes) and 
CDR3 sequence combinations. Such biases may reflect the 
need for a conserved structural framework and peptide con- 
tact sites in TcR recognition events (16). 
Simultaneous screening of samples for TcR gene rear- 
rangements or their transcription of messenger ribonucleic 
acid (RNA) has been facilitated greatly by the availability of 
PCR-based TcR V region gene phenotyping. Using this tech- 
nique, in both humans and animal models, restricted heter- 
ogeneity of the T cell response was detected in several au- 
toimmune diseases (17-20), including thyroid autoimmune 
diseases and GO (21-24). In addition, we recently demon- 
strated restricted usage of TcR V region gene families in T 
lymphocytes derived from pretibial biopsies of patients with 
active PTD (25). Although these studies suggested that spe- 
cific antigens are targeted by T lymphocytes present at these 
distinct sites, analysis of intrathyroidal, retroorbital, and 
pretibial TcR V gene repertoires in individual patients has 
been prohibited by the lack of appropriate study material. 
Comparative analysis of local TcR V gene usage at the in- 
volved sites of individual patients with GD may help to 
determine whether the hypothesis of a shared antigen be- 
tween the thyroid gland and the extrathyroidal manifesta- 
tions is supported at the molecular T cell level. 
In this study, using PCR-based phenotyping of TcR V 
region genes and sequencing of junctional regions of dom- 
inant V/3 genes, we analyzed the expression of the known Va 
and VP gene families in T cells infiltrating the thyroid gland 
and various extrathyroidal sites of two patients with GD, 
severe ophthalmopathy, and PTD. Our results indicate oli- 
goclonality of TcRs and striking similarities of TcR V gene 
repertoires at the intra- and extrathyroidal manifestations in 
these two patients with GD. 
Materials and Methods 
Study subjects 
Patient 1, a 54.yr-old white female, presented to her local physician 
in June 1993 with palpitations, sweating, irritability and a 9-lb weight 
loss. She had previously been healthy except for chronic bronchitis due 
to heavy smoking (25 cigarettes/ day). Graves’ hyperthyroidism was 
diagnosed based on typical clinical signs and symptoms, the presence 
of mild bilateral ophthalmopathy, and heterogeneous, markedly ele- 
vated technetium uptake of 9.6% on thyroid scintigraphy. Thyroid func- 
tion tests were as follows: basal TSH, less than 0.03 mEq/L; free T,, 580 
pg/L; free T,, 14.7 fg/L; thyroglobulin antibodies, 480 mu/L; thyroid 
peroxidase antibodies, 1600 mu/L; and TSH receptor stimulating index, 
17.8, as determined by stimulation of CAMP production in rat thyroid 
cells. Thyroid ultrasound revealed a large multinodular goiter (78 mL) 
with marked hypoechogenicity. Antithyroid medication with carbima- 
zole (20 mg, orally, twice daily) was started; however, the patient was 
still hyperthyroid after 3 weeks of therapy. A euthyroid state was 
achieved only after the carbimazole dose had been increased to 60 
mg/day. Near-total thyroidectomy was performed without complica- 
tions, and a small piece of thyroid tissue was immediately frozen in 
liquid nitrogen. Four months later, while the patient was euthyroid with 
replacement therapy of 125 wg/day levothyroxine, progression of oph- 
thalmopathy was noted by her ophthalmologist; however, treatment 
with glucocorticosteroids or orbital irradiation was not initiated. Smok- 
ing was strongly discouraged, with minimal success. Two months later, 
the patient presented with an infiltrative dermopathy that extended over 
both anterior pretibial areas. Lesional biopsies, taken from both legs for 
immunohistochemical studies, were consistent with pretibial dermop- 
athy. One deep biopsy specimen was quickly frozen in liquid nitrogen 
and reserved for further study. In January 1994, the patient was referred 
for progressive severe ophthalmopathy. Marked bilateral proptosis, 
periorbital edema, diplopia, left optic neuropathy, and incipient expo- 
sure keratitis of the left eye due to incomplete lid closure were noted. 
Urgent surgical decompression of the left orbit was performed, resulting 
in rapid recovery of optic nerve function and restoration of lid closure. 
During the surgical procedure, a small biopsy of retroorbital connective 
tissue was frozen in liquid nitrogen, and a blood sample was taken for 
preparation of peripheral blood mononuclear cells. Postoperatively, the 
patient underwent orbital irradiation and oral glucocorticoid therapy, 
with acceptable long term success. Human leukocyte antigen (HLA) 
haplotyping of patient 1 revealed HLA class I (A2,87, Bw57, Cw6), HLA 
class II (DR2 DR7). 
Patient 2, a 44-yr-old white female, presented for evaluation of pro- 
gressive periorbital swelling and visual impairment. She had been di- 
agnosed with Graves’ hyperthyroidism 3 yr ago and undergone suc- 
cessful treatment with radioiodine, followed by supplementation with 
75 pg/day levothyroxine. Thyroid function tests confirmed a euthyroid 
state (TSH, 1.2 mu/L; free T, 14Opg/L; free T,, 2.9 fg/L)and a markedly 
elevated TSH receptor stimulating index of 21. Eye examination revealed 
the presence of severe ophthalmopathy, disfiguring bilateral periorbital 
edema, marked proptosis of the right globe, diplopia due to profound 
extraocular muscle dysfunction, and right optic neuropathy. Computed 
tomography of the orbits suggested compression of the right optic nerve 
at the orbital apex by markedly enlarged extraocular muscles. Orbital 
decompression of the right orbit was performed and resulted in rapid 
improvement of optic nerve functions and periorbital swelling. A small 
biopsy specimen was obtained from the retroorbital connective tissue 
and stored in liquid nitrogen for further analysis. In addition, several 
biopsies were taken from an area of diffuse thickening and redness of 
the skin that extended from the pretibial area to the forefoot of her left 
leg. Histology was consistent with pretibial dermopathy. HLA haplo- 
typing of patient 2 revealed HLA class I (Al, AZ, B13, Cw6, Cw7), HLA 
class II (DR2, DR7). 
In addition, biopsies of thyroid, retroorbital, and pretibial tissue were 
obtained from two females (48 and 61 yr of age, respectively) who died 
from fatal myocardial infarction. None of these individuals had a per- 
sonal or family history of GD, GO, or systemic or organ-specific auto- 
immune disease. Thyroid function studies were normal, and thyroid 
autoantibodies were not detected. 
Sample preparations 
Biopsies, taken from thyroid gland, retroorbital tissue, and pretibial 
skin, were rapidly frozen in liquid nitrogen for subsequent RNA ex- 
traction. Peripheral blood lymphocytes (PBL) were prepared from he- 
parinized blood by Ficoll-Hypaque density-gradient centrifugation 
(Pharmacia, Piscataway, NJ) and stored in liquid nitrogen. Immunohis- 
tochemical staining of T lymphocytes in frozen sections was performed 
using monoclonal antibodies directed against CD2, CD3, CD4, and CD8 
(Becton Dickinson, Mountain View, CA); CD45RO (Dakopatts Corp., 
Santa Barbara, CA); a/p TcR (Identi T PFl, p-chain specific) and TcRy/ 6 
(TcRGl; T Cell Science Co., Cambridge, MA); TcRVP2 (Dianova, Ham- 
burg, Germany); and TcRVP6 (T Cell Diagnostics, Woburn, MA) and 
biotinylated secondary antibodies in conjunction with the Vectastain 
Peroxidase ABC elite kit (Vector Laboratories, Burlingame, CA), as de- 
scribed previously (9, 24). 
PCR analysis of TcR Vgenes 
TcR V gene analysis was performed as previously described (24, 25). 
In brief, total RNA was extracted from cryostat sections and PBL, reverse 
transcribed to complementary DNA (cDNA), and amplified using 22 Va 
family-specific primers and 23 VP family-specific primers, each paired 
with a 3’.primer matched to a single constant region of the Va gene (Ccu) 
and VP gene (Cp). T cell antigen receptor V gene-specific primer se- 
quences, oligonucleotide probe sequences, and the expected sizes of the 
PCR products were previously reported (24). To avoid technical arti- 
facts, samples were prepared and analyzed together. Southern hybrid- 
ization was performed to increase the sensitivity of fragment detection 
and to verify the specificity of PCR products, as previously reported (24). 
The proportions of TcR V genes expressed were determined by com- 
puterized quantitative densitometry of autoradiographs. Each TcR Va 
or VP gene was expressed as a percentage of all of the Va or VP genes 
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detected on that scan, respectively. Control experiments were performed 
as previously described (24). Comparable quantities of TcR-specific 
cDNA, as indicated by the yield of TcR C region-specific transcripts, 
were subjected to PCR analysis. Hybridization conditions were of suf- 
ficient stringency to allow for specific detection of fragments of defined 
and predicted size (24). 
Cloning and sequencing of cDNAs encoding TcR V/3 genes 
Amplified cDNAs encoding particular TcR V genes from T cells 
infiltrating the thyroid gland or extrathyroidal were size-fractionated on 
2% agarose gels and purified using the Qiaex agarose gel extraction 
procedure (Qiagen, Chatsworth, CA). Purified DNA fragments were 
ligated into pCR II T/A cloning vector (Invitrogen, San Diego, CA) and 
used to transform bacterial cells. Independent recombinants were iden- 
tified by antibiotic selection and a /3-galactosidase calorimetric assay. 
Individual bacterial colonies were grown overnight in minicultures and 
screened subsequently by DNA blot hybridization using a TcR Cp- 
snecific horseradish ueroxidase urobe. Plasmid DNA was uurified from 
dositively hybridizing bacteria{ lysates using Qiaex silica matrix and 
eluted in 30 PL dH,O. Half of the plasmid miniprep was subjected to 
double stranded DNA sequencing using T7 and SP6 primers, respec- 
tively, and the Sequenase V.2 protocol (U.S. Biochemical Corp., Cleve- 
land, OH). Nucleic acid and protein sequence comparisons were con- 
ducted using GenBank and EMBL libraries. 
Results 
Immunoperoxidase detection of TcR chains 
Immunohistochemistry of sections derived from thyroid, 
retroorbital, and pretibial tissue samples of both patients 
revealed the presence of CD3+ T cells. The vast majority of 
T lymphocytes (-96-98%) were a/ p’ T cells, as determined 
by positive immunoreactivity with a P-chain-specific human 
TcR antibody (data not shown). Except for occasional cells 
immunoreactive with the human TcR &chain-specific mono- 
clonal antibody, y6+ T cells were not detected in thyroid, 
retroorbital, and pretibial specimens of either patient. 
T cell antigen receptor V gene analysis 
Expression of a broad spectrum of TcR Vol and V/3 genes 
was detected in cDNA samples prepared from PBL of either 
patient (Fig. 1; l:B and 2:B) and two control individuals (data 
not shown). In these samples, between 19-20 Va genes and 
between 20-22 VP genes, respectively, were actively tran- 
scribed. Compared with PBL, restriction of TcR Va and TcR 
VP genes (<50% of individual genes rearranged and ex- 
pressed) was detected in thyroid (7 of 22 Va! gene families; 
10 of 23 V/3 gene families), retroorbital (9 of 22 Vcr gene 
families; 10 of 23 VP gene families), and pretibial(8 of 22 Va 
gene families; 9 of 23 V/3 gene families) tissue obtained from 
patient 1 (Fig. 1). Similarly, marked restriction of TcR V~Y and 
TcR VP genes was detected in retroorbital (8 of 22 Va gene 
families; 8 of 23 VP gene families) and pretibial (8 of 22 Va 
gene families; 8 of 23 VP gene families) tissue obtained from 
patient 2 (Fig. 1). The presence of dominant TcR VP2 and V/36 
gene products in thyroid, orbital, and pretibial tissue of pa- 
tient 1 and in orbital and pretibial tissue of patient 2 was 
further confirmed by immunohistochemical staining using 
monoclonal antibodies directed against human TcR VP2 and 
TcR V/36 gene families, respectively (Fig. 2). Further, unre- 
stricted TcR Va or V/3 gene usage was detected in samples 
derived from the thyroid gland of two control individuals. 
TcR V gene analysis of retroorbital and pretibial specimens 
derived from these two control individuals failed to yield 
TcR-specific transcripts (not shown). 
Despite obvious heterogeneity of the TcR V gene reper- 
toire between patients 1 and 2, marked similarities of re- 
stricted Va and VP gene family usage were noted in T cells 
infiltrating the thyroid gland, retroorbital connective tissue, 
and pretibial skin of either patient. For example, the presence 
of Va2, Va3, V&3, VaI2, Va15, Va21, Vp2, V/34, Vp6, Vp7, 
Vp12, Vp20, and VP24 transcripts, was shared by thyroid, 
retroorbital, and pretibial tissue of patient 1. Further, Vcr3, 
Va8, VaI2, V(~l4, Va19, Vp2, Vp4, V/36, V/312, VPIS, and 
VP23 transcripts were present in both retroorbital and 
pretibial tissue obtained from patient 2. 
DNA sequencing was used to determine the amino acid 
sequences of dominant TcR V gene families that contributed 
20% or more of the total VP gene activity detected at indi- 
vidual sites. TcRs using VP6 (patient 1) and VP2 (patient 2) 
genes, respectively, were amplified by PCR and ligated into 
pCR II T/A cloning vector. Multiple TcRs were then isolated 
from these libraries and sequenced. The results of this anal- 
ysis are summarized in Table 1. Overexpressed VP2 and V/36 
gene families from thyroid, orbital, and pretibial tissues of 
patients 1 and 2, respectively, revealed major populations of 
clonally expanded TcRs or TcRs whose rearrangements 
shared significant homologies at the amino acid level of 
junctional regions. As demonstrated by sequence analysis of 
51 VP6 TcR cDNA clones derived from the involved tissue 
sites (thyroid, orbit, and pretibium) of patient 1 and of 29 V/32 
TcR cDNA clones from the orbit and pretibium of patient 2, 
single TcR rearrangements accounted for up to 53% (intra- 
thyroidal TcRs in patient 1) of a given TcR family. One TcR 
clone using V/36.2 (V/36.2-JP2.1) was detected in thyroidal, 
orbital, and pretibial tissue of patient 1. In addition, a re- 
stricted number of J/3 gene family members was detected in 
distinct tissue sites of either patient. Of the 13 Jp gene family 
members, only 4 (Jp1.6, -2.1, -2.2, and -2.3) were used by 
intrathyroidal, orbital, and pretibial TcR V/36 clones in pa- 
tient 1, and 5 (Jp 1.5, -2.1, -2.2, -2.3, and 2.7) were preferen- 
tially used by orbital and pretibial TcR VP2 clones in patient 
2. Further, comparison of the CDR3 domains of junctional 
regions in expanded VP TcR revealed several conserved 
amino acid motifs that were shared by intrathyroidal, orbital, 
and pretibial lymphocytes in either patient (Table 1). In V/36 
TcRs of patient 1, the motif G-L-A was used by the dominant 
intrathyroidal clonotype, and by one of the clonally ex- 
panded V/36 orbital and pretibial TcRs, respectively. Simi- 
larly, in patient 2, the motifs E-R-G and G-Q-E-L were shared 
by clonally expanded VP2 orbital and pretibia1 TcRs, respec- 
tively. In contrast, none of the dominant rearrangements was 
found among VP2 and V/36 TcR cloned from PBL from either 
patient. These results indicate that certain populations of 
intrathyroidal, orbital, and pretibial lymphocytes in these 2 
patients were oligoclonal, and that several clones were 
present at a high frequency in these distinct sites. 
Discussion 
T lymphocytes are thought to play a crucial role in the 
pathogenesis of GD, GO, and PTD (1,2,10,24,25). Analysis 
of lymphocytes infiltrating the retroorbital and pretibia1 
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FIG. 1. TcR Vo and VP gene family us- 
age in tissue samples derived from thy- 
roid gland, orbital connective tissue, 
and pretibial skin of patient 1 (top 
panel) and patient 2 (bottom panel). 
RNA was extracted from frozen sections 
of tissue biopsies, transcribed to cDNA, 
and amplified by the PCR using 22 VLY 
and 23 VP primer pairs. The resulting 
transcripts were detected autoradio- 
graphically after Southern hybridiza- 
tion with digoxigenin-labeled TcR o- 
and p-chain-specific constant region oli- 
gonucleotide probes. The relative pro- 
portions of individual TcR Vo and VP 
genes detected were determined by 
quantitative densitometry and ex- 
pressed as percentages (percent contri- 
bution) of the 22 Vo and 23 VP genes 
examined. Only TCR Vo and VP genes 
with a more than 1% overall contribu- 
tion are depicted. In patient 1, intra- 
thyroidal (T), orbital (0), and pretibial 
(P) TcRVa and VP gene usage is shown. 
In patient 2, orbital (0), and pretibial 
(P) TcR Vo and VP gene usage is dem- 
onstrated. In addition, nonrestriction of 
peripheral blood (B) TcR Vol and VP 
gene usage was present in both 
patients. 
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space of patients with GO and PTD revealed the presence of CD3+ / CD45RO+ cells, reflecting a subset of memory T cells 
both CD4+ and CD8+ T lymphocytes, with a variable pre- and macrophages (8). However, the autoantigens recognized 
dominance of the latter (1, 2, 6, 7). A significant proportion by autoreactive T cells infiltrating the thyroidal and extra- 
of T lymphocytes, frequently adjacent to blood vessels, are thyroidal manifestations of patients with GD have not been 
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FIG. 2. Immunoperoxidase localization of TcR Vp6’ lymphocytes in 
a cryostat section of retroorbital connective tissue derived from pa- 
tient 1 with GD, severe ophthalmopathy, and pretibial dermopathy. 
Infiltration of retroorbital connective tissue by TcRVPG+ lymphocytes 
(arrows) is demonstrated. Original magnification, x250. 
identified (10). In a recent study, CD8+ CD45RO+ orbit- 
infiltrating T lymphocytes from patients with GO were dem- 
onstrated to selectively recognize autologous fibroblasts de- 
rived from retroocular connective tissue and, to a lesser 
degree, other anatomical locations (14). These results support 
the concept that connective tissue fibroblasts represent major 
targets for T cells that infiltrate the extrathyroidal manifes- 
tations associated with GD (26). Recent data from several 
laboratories have demonstrated TcR V gene restriction in 
both animal models and human autoimmune diseases, sup- 
porting a central role for T cells in the initiation and prop- 
agation of autoimmunity (17-20). In support of this concept, 
evidence of limited variability of intrathyroidal TcR V genes 
in GD has been demonstrated (21-23), although conflicting 
results have also been reported (27, 28). We have recently 
detected restriction of TcR V gene usage in retroorbital con- 
nective tissue of patients with active GO of recent onset, 
whereas TcR V gene usage was unrestricted in patients with 
long standing, inactive GO (24). In addition, analysis of T cell 
surface markers and TcRs expressed by lymphocytes infil- 
trating the pretibial space of patients with clinically active 
PTD revealed a predominance of CD3+ T lymphocytes, 
many of which are CD@ T cells and express TcR (Y / p-chains 
(25). Marked restriction of TcR Va and VP gene usage was 
demonstrated in lymphocytes infiltrating the pretibial tissue 
of patients with early active PTD, whereas greater diversity 
of VP gene usage and loss of Vo gene restriction were ob- 
served in patients with long standing pretibial dermopathy 
(25). These results suggested that the primary target antigen 
in GO and PTD may initiate a restricted T cell V gene re- 
sponse, and that later in the natural history of the disease, 
tissue destruction and cytokine-induced antigen expression 
may promote the recruitment of a more diverse spectrum of 
T cells that use multiple TcR V gene families, and react to a 
variety of tissue-specific and tissue-nonspecific antigens (29). 
We hypothesized that among the inflammatory cells in- 
filtrating thyroid, retroorbital, and pretibial tissues of indi- 
vidual patients with GD, subpopulations of autoantigen- 
reactive T cells may be responsible for initiating and 
perpetuating the immune process. To identify such disease- 
associated T cells, we have analyzed the patterns of TcR-ap 
gene expression and sequenced the junctional regions of 
dominating TcR VP genes in thyroid, retroorbital, and 
pretibial tissue samples derived from two patients with GD, 
GO and PTD. Although the spectrum of actively transcribed 
TcR Va and V/3 genes varied among the various samples 
derived from either patient, several striking features were 
noted. Marked restriction of the TcR V gene repertoire and 
overexpression of certain TcR V gene segments were de- 
tected in lymphocytes infiltrating thyroid, orbital, and 
pretibial skin. Heterogeneity of TcR V gene usage may be 
explained by the fact that the TcR recognizes similar anti- 
genie peptides in the context of HLA molecules, which were 
different in the two patients studied. Individual HLA gene 
endowment may play an important role in shaping the TcR 
V gene repertoire (30,31), and this may influence TcR V gene 
usage in lymphocytes capable of recognizing common anti- 
genie epitopes presented at distinct involved sites in GD. 
Given the marked similarity in individual TcR V genes ex- 
pressed by lymphocytes infiltrating distinct anatomical sites, 
our results suggest that infiltrating T cells might recognize a 
limited range of antigenic epitopes shared by the thyroid 
gland, retroorbital connective tissue, and pretibial skin. 
Furthermore, our data indicate that analogous mecha- 
nisms may act to control T cell selection and expansion 
within both the thyroid gland and the involved extrathy- 
roidal compartments. 
To define further the significance of dominating V/32 and 
VP6 gene families in thyroid, retroorbital, and pretibial tissue 
of patients 1 and 2, we next examined the clonotypic heter- 
ogeneity of these T cells. Sequence analysis of the junctional 
regions of V/36 and V/32 genes revealed a limited number of 
independently rearranged TcR p-chain genes, the presence of 
conserved amino acid residues within the CDR3 region, and 
selective usage of related J/I gene family members by V/36+ 
and V/32” T cells infiltrating distinct tissues in the two pa- 
tients studied. By contrast, limited clonotypic heterogeneity 
and biased JP gene usage were not detected among patients’ 
PBL or in tissue controls obtained from healthy individuals. 
The CDR3 region is commonly associated with fine antigenic 
specificity, and TcRs selected by defined antigenic peptides 
often show homologous amino acid motifs in the junctional 
region (16). Accordingly, detection of conserved CDR3 mo- 
tifs in clonally expanded TcR from distinct anatomical sites 
is consistent with T cell activation by antigens bearing shared 
antigenic determinants. Given the similarity of certain HLA 
alleles in the two patients studied, detection of conserved 
junctional motifs may reflect the influence of common HLA 
alleles on TcR selection. The presence of conserved junctional 
CDR3 motifs joined to different V/3 segments has been re- 
ported in several HLA class I-restricted T cell lines and T cell 
clones specific for the same peptide/MHC complex or in 
tissues affected by autoimmune conditions, such as giant cell 
arteritis (32,33). Thus, homologous junctional regions appear 
to confer specificity for the same antigenic determinant even 
if associated with different V/3 segments. Our detection of a 
limited number of independently rearranged TcR p-chain 
genes together with selective usage of related TcR JP gene 
3738 HEUFELDFER ET AL. JCE & M l 1996 
I’0181 . No 10 
Table 1. Summary of junctional sequence analysis of TcR VP genes in T lymphocytes rescued from thyroid, orbital, pretibial tissue, and 
peripheral blood of two patients with Graves’ disease, ophthalmopathy, and pretibial myxedema 
Patient no. SOLUW TcR V/3 No. of clones B of total 
TcRp-V-N(D)N-J junctional sequences 
VP N-DP-N region” JP 
Thyroid 
Orbit 
Pretibium 
Blood 
Orbit 
Pretibium 
Blood 
VP6 8115 53.3 V86.2-CASS RGLA 2.1 
3115 20.0 V66.2 CASSL GTAS 2.2 
1115 6.7 V66.2 CASS YSGIT 2.1 
VP6 5117 29.4 V66.1 CASSL GQG 2.1 
2117 11.8 V86.2 CASS DGLA 2.3 
VP6 7119 36.8 V66.2 CASSL PGGGR 2.1 
2119 10.5 V66.2 CASS LAGGLG 2.3 
2119 10.5 V66.2 CASSL D&A 1.6 
VP6 o/19 0 
VP2 6116 37.5 V/32.1 CSA TGQELG 1.5 
5116 31.3 V62.3 CSAR GmS 2.3 
2116 12.5 V62.3 CSAR DPmA 2.7 
VP2 4113 30.8 V62.1 CSA RTAY 2.1 
2/13 15.4 V62.1 CSA NGQELV 2.1 
l/13 7.7 V62.1 CSA RDN 2.2 
VP2 o/19 0 
a The single letter amino acid sequences at the 3’-position of TcR VP and at the CDR3 region are given. Repetitive amino acid motifs within 
the junctional regions are underlined. 
family members by VP2 and V/36 T cells infiltrating thyroid, 
retroorbital, and pretibial tissues suggest clonal restriction of 
these cells, perhaps in response to local stimulation by one 
or a limited number of antigenic determinants present in 
these distinct anatomical locations. Although the significance 
of this apparent bias remains unclear, it is interesting to 
speculate that the Vp6.2-Jp2.1 clonotype may define a dis- 
tinct antigenic reactivity, perhaps unique to patient 1. It is 
likely that Vp2- and V/36-positive T cells proliferate due to 
antigen-driven stimulation through MHC-antigen-TCR 
complexes, although the possibility that these cells prolifer- 
ate in response to a superantigen must be considered. 
Involvement of VP2+ and Vp6’ T lymphocytes has been 
observed in several other immune responses affecting gut 
(34, 35), muscle (36), and skin (37, 38). Clonally expanded 
VP6+ T cells appear to confer protective immunity to My- 
cobacterium leprae (39), and V/32+ and Vp6+ T lymphocytes 
have been attributed antitumor activity against squamous 
cell carcinomas (40). In addition, V/32 and VP6 TcRs are 
highly expressed in the intestinal mucosa (35). In GD and its 
associated extrathyroidal manifestations, recent evidence 
suggests that the immune response may be directed against 
certain antigenic determinants that are present in epithelial 
(thyroid, skin, and orbit) and mucosal (lacrimal gland) tissue 
components (41, 42). Thus, in view of our previous and 
current data, and the proposed functions of V/32 and V/36 
TcRs in conveying immunosurveillance over mucosal and 
epithelial surfaces, the role of VP2 and VP6 TcRs in GD 
warrants further study. 
Although the antigens to which T cells infiltrating thyroid, 
retroorbital, and pretibial tissue in patients with GD respond 
are unknown, delineation of antigenic reactivities associated 
with tissue-infiltrating T lymphocytes of patients with GD 
may help to clarify the significance of the TcR restrictions 
identified in this study. Analysis of ligands, including self- 
antigens and HLA alleles, that are recognized by restricted 
autoreactive T cells should shed light on the mechanisms 
involved in the evolution of the extrathyroidal manifesta- 
tions of GD. Thus, if the recurrent character of TcR rear- 
rangements in T cells infiltrating the involved tissues could 
be confirmed in a larger number of patients with GD who 
share certain HLA alleles, this approach might ultimately 
provide a basis for targeted immunotherapy in patients with 
thyroidal and extrathyroidal manifestations of GD. 
In conclusion, we have demonstrated restriction of TcR Va 
and V/3 gene usage and overexpression of certain dominating 
TcR Va and VP gene families in thyroid, retroorbital, and 
pretibial tissue of two patients with GD. Furthermore, de- 
tection of TcR oligoclonality and marked homology of TcR 
V genes rearranged and expressed by T cells infiltrating into 
these anatomically distinct tissues indicate that similar mech- 
anisms may act to locally control T cell recruitment and 
expansion within thyroid, orbital, and pretibial tissues in GD. 
These similarities may be considered molecular evidence 
that some of the clonally expanded intrathyroidal T cells 
were strongly selected. Thus, our data are consistent with the 
hypothesis that in GD, common antigenic determinants may 
drive the immune response against the thyroid gland and 
certain extrathyroidal sites. Although the nature of the an- 
tigen and the mechanisms leading to its recognition by the 
immune system await further study, the expression of certain 
antigenic epitopes by a cell type common to the thyroid gland 
and the affected extrathyroidal tissues remains a strong 
possibility. 
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